The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction
Abstract
CONTEXT: Only limited information is available on the speed of implementation of new evidence-based and guideline-recommended treatments and its association with survival in real life health care of patients with ST-elevation myocardial infarction (STEMI). OBJECTIVE: To describe the adoption of new treatments and the related chances of short- and long-term survival in consecutive patients with STEMI in a single country over a 12-year period. DESIGN, SETTING, AND PARTICIPANTS: The Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) records baseline characteristics, treatments, and outcome of consecutive patients with acute coronary syndrome admitted to almost all hospitals in Sweden. This study includes 61,238 patients with a first-time diagnosis of STEMI between 1996 and 2007. MAIN OUTCOME MEASURES: Estimated and crude proportions of patients treated with different medications and invasive procedures and mortality over time. RESULTS: Of evidence-based treatments, reperfusion increased from 66% (95%, confidence interval [CI], 52%-79%) to 79% (95% CI, 69%-89%; P < .001), primary percutaneous coronary intervention from 12% (95% CI, 11%-14%) to 61% (95% CI, 45%-77%; P < .001), and revascularization from 10% (96% CI, 6%-14%) to 84% (95% CI, 73%-95%; P < .001). The use of aspirin, clopidogrel, β-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors all increased: clopidogrel from 0% to 82% (95% CI, 69%-95%; P < .001), statins from 23% (95% CI, 12%-33%) to 83% (95% CI, 75%-91%; P < .001), and ACE inhibitor or angiotensin II receptor blockers from 39% (95% CI, 26%-52%) to 69% (95% CI, 58%-70%; P < .001). The estimated in-hospital, 30-day and 1-year mortality decreased from 12.5% (95% CI, 4.3%-20.6%) to 7.2% (95% CI, 1.7%-12.6%; P < .001); from 15.0% (95% CI, 6.2%-23.7%) to 8.6% (95% CI, 2.7%-14.5%; P < .001); and from 21.0% (95% CI, 11.0%-30.9%) to 13.3% (95% CI, 6.0%-20.4%; P < .001), respectively. After adjustment, there was still a consistent trend with lower standardized mortality over the years. The 12-year survival analyses showed that the decrease of mortality was sustained over time. CONCLUSION: In a Swedish registry of patients with STEMI, between 1996 and 2007, there was an increase in the prevalence of evidence-based treatments. During this same time, there was a decrease in 30-day and 1-year mortality that was sustained during long-term follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Task Force Members, Thygesen, K., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,541
Authors/Task Force Members, Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,310
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
Yeh, R. W., Sidney, S., Chandra, M., Sorel, M., Selby, J. V., & Go, A. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908610 · Cited by 1,735
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Jernberg, T., Attebring, M. F., Hambraeus, K., Ivert, T., James, S., Jeppsson, A., Lagerqvist, B., Lindahl, B., Stenestrand, U., & Wallentin, L. (2010) · Heart · doi:10.1136/hrt.2010.198804 · Cited by 773
Self-citationPeterson, E. D., Roe, M. T., Mulgund, J., DeLong, E. R., Lytle, B. L., Brindis, R. G., Smith, S. C., Pollack, C. V., Newby, L. K., Harrington, R. A., et al. (2006) · JAMA · doi:10.1001/jama.295.16.1912 · Cited by 672
Widimsky, P., Wijns, W., Fajadet, J., de Belder, M., Knot, J., Aaberge, L., Andrikopoulos, G., Baz, J. A., Betriu, A., Claeys, M., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp492 · Cited by 657
De Luca, G., Suryapranata, H., Stone, G. W., Antoniucci, D., Tcheng, J. E., Neumann, F.-J., Van de Werf, F., Antman, E. M., & Topol, E. J. (2005) · JAMA · doi:10.1001/jama.293.14.1759 · Cited by 614
Franzosi, M. G., Santoro, E., Zuanetti, G., Baigent, C., Collins, R., Flather, M. D., Kjekshus, J., Latini, R., Liu, L., Maggioni, A. P., et al. (1998) · Circulation · Cited by 536
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
Stenestrand, U. (2001) · JAMA · doi:10.1001/jama.285.4.430 · Cited by 530
Dagenais, G. R., Pogue, J., Fox, K., Simoons, M. L., & Yusuf, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69201-5 · Cited by 514
Mehta, R. H. (2002) · JAMA · doi:10.1001/jama.287.10.1269 · Cited by 477
Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction
Roger, V. L., Weston, S. A., Gerber, Y., Killian, J. M., Dunlay, S. M., Jaffe, A. S., Bell, M. R., Kors, J., Yawn, B. P., & Jacobsen, S. J. (2010) · Circulation · doi:10.1161/circulationaha.109.897249 · Cited by 335
The Myocardial Ischaemia National Audit Project (MINAP)
Herrett, E., Smeeth, L., Walker, L., Weston, C., & on behalf of the MINAP Academic Group (2010) · Heart · doi:10.1136/hrt.2009.192328 · Cited by 297
Flynn, M. R., Barrett, C., Cosío, F. G., Gitt, A. K., Wallentin, L., Kearney, P., Lonergan, M., Shelley, E., & Simoons, M. L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi079 · Cited by 162
The NCDR ACTION Registry–GWTG: transforming contemporary acute myocardial infarction clinical care
Peterson, E. D., Roe, M. T., Chen, A. Y., Fonarow, G. C., Lytle, B. L., Cannon, C. P., & Rumsfeld, J. S. (2010) · Heart · doi:10.1136/hrt.2010.200261 · Cited by 138
Floyd, K., Yarzebski, J., Spencer, F. A., et al. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.811828 · Cited by 137
Acute Myocardial Infarction Hospitalization in the United States, 1979 to 2005
Fang, J., Alderman, M. H., Keenan, N. L., & Ayala, C. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.08.018 · Cited by 97
Statin and β-Blocker Therapy and the Initial Presentation of Coronary Heart Disease
Go, A. S., Iribarren, C., Chandra, M., Lathon, P. V., Fortmann, S. P., Quertermous, T., Hlatky, M. A., & for the Atherosclerotic Disease, V. F. A. G. E. (. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00004 · Cited by 89
Stenestrand, U., Lindbäck, J., & Wallentin, L. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.018 · Cited by 31
Mehta, R. H., Montoye, C., Gallogly, M., Baker, P. L., Blount, A. C., Borzak, S. L., Kline-Rogers, E. M., Lalonde, T. A., Orza, M. J., Parrish, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)82034-4 · Cited by 7
Cited by
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 676
Metadata
- Authors
- Jernberg, T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-04-27
- Volume
- 305
- Issue
- 16
- Pages
- 1677
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2084826452
- Cited by
- 464
- References
- 30
- FWCI
- 30.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.